Crinetics Pharmaceuticals IncNASDAQ:CRNX
- LAST PRICE57.9600
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots23.1900/ 2
- Ask / Lots92.1500/ 1
- Open / Previous Close--- / 57.9600
- Day Range---
- 52 Week Range
- Volume118
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CRNX |
|---|---|---|
| 09:32 ET | 2359 | 59.14 |
| 09:34 ET | 260 | 59.06 |
| 09:36 ET | 2487 | 58.54 |
| 09:38 ET | 140 | 58.985 |
| 09:39 ET | 320 | 58.47 |
| 09:43 ET | 240 | 58.5 |
| 09:45 ET | 300 | 59.11 |
| 09:48 ET | 200 | 58.84 |
| 09:50 ET | 1300 | 58.95 |
| 09:52 ET | 700 | 59.085 |
| 09:54 ET | 1450 | 58.82 |
| 09:56 ET | 340 | 58.81 |
| 09:57 ET | 300 | 58.6 |
| 09:59 ET | 100 | 58.71 |
| 10:01 ET | 120 | 58.725 |
| 10:03 ET | 450 | 58.66 |
| 10:06 ET | 900 | 58.53 |
| 10:08 ET | 531 | 58.62 |
| 10:10 ET | 200 | 58.615 |
| 10:12 ET | 100 | 58.615 |
| 10:15 ET | 240 | 58.47 |
| 10:17 ET | 430 | 58.615 |
| 10:19 ET | 530 | 58.74 |
| 10:21 ET | 1400 | 59 |
| 10:24 ET | 810 | 59.09 |
| 10:26 ET | 600 | 59.21 |
| 10:28 ET | 15500 | 59.065 |
| 10:30 ET | 2520 | 59.23 |
| 10:32 ET | 2085 | 59.015 |
| 10:33 ET | 660 | 58.8 |
| 10:35 ET | 140 | 58.8 |
| 10:37 ET | 120 | 58.8 |
| 10:39 ET | 120 | 58.68 |
| 10:42 ET | 1140 | 59.01 |
| 10:44 ET | 100 | 58.935 |
| 10:46 ET | 200 | 58.845 |
| 10:48 ET | 300 | 58.845 |
| 10:50 ET | 200 | 58.845 |
| 10:51 ET | 1270 | 59.12 |
| 10:53 ET | 7200 | 59.095 |
| 10:55 ET | 400 | 58.99 |
| 10:57 ET | 680 | 59.03 |
| 11:00 ET | 380 | 58.98 |
| 11:02 ET | 300 | 59.07 |
| 11:06 ET | 200 | 59.05 |
| 11:08 ET | 200 | 59.115 |
| 11:09 ET | 500 | 59.115 |
| 11:11 ET | 670 | 59.12 |
| 11:13 ET | 7195 | 59.0575 |
| 11:15 ET | 800 | 59.1 |
| 11:18 ET | 520 | 59.16 |
| 11:20 ET | 100 | 59.165 |
| 11:22 ET | 1520 | 59.16 |
| 11:24 ET | 720 | 59.03 |
| 11:26 ET | 300 | 59.05 |
| 11:27 ET | 2040 | 59.05 |
| 11:29 ET | 500 | 59.03 |
| 11:31 ET | 131 | 58.97 |
| 11:33 ET | 300 | 59.01 |
| 11:36 ET | 1100 | 58.93 |
| 11:38 ET | 100 | 58.915 |
| 11:40 ET | 500 | 58.83 |
| 11:45 ET | 100 | 58.795 |
| 11:49 ET | 100 | 58.8 |
| 11:51 ET | 610 | 58.965 |
| 11:54 ET | 1000 | 58.97 |
| 11:56 ET | 200 | 58.955 |
| 11:58 ET | 100 | 58.955 |
| 12:02 ET | 200 | 58.93 |
| 12:03 ET | 400 | 59 |
| 12:05 ET | 300 | 59.04 |
| 12:07 ET | 300 | 59.04 |
| 12:09 ET | 1133 | 59.02 |
| 12:12 ET | 400 | 59.1 |
| 12:16 ET | 500 | 59.13 |
| 12:18 ET | 2100 | 59.14 |
| 12:20 ET | 1800 | 59.1 |
| 12:21 ET | 500 | 59.09 |
| 12:23 ET | 500 | 59.12 |
| 12:25 ET | 940 | 59.12 |
| 12:27 ET | 200 | 59.12 |
| 12:30 ET | 220 | 59.03 |
| 12:32 ET | 1400 | 59.12 |
| 12:36 ET | 834 | 58.96 |
| 12:38 ET | 120 | 58.89 |
| 12:39 ET | 1105 | 58.86 |
| 12:41 ET | 200 | 58.89 |
| 12:43 ET | 100 | 58.9 |
| 12:48 ET | 300 | 59 |
| 12:50 ET | 19300 | 58.96 |
| 12:52 ET | 300 | 58.84 |
| 12:54 ET | 900 | 58.45 |
| 12:56 ET | 100 | 58.565 |
| 12:57 ET | 200 | 58.58 |
| 01:01 ET | 700 | 58.45 |
| 01:03 ET | 113 | 58.56 |
| 01:06 ET | 200 | 58.43 |
| 01:12 ET | 800 | 58.285 |
| 01:15 ET | 967 | 58.25 |
| 01:19 ET | 200 | 58.255 |
| 01:24 ET | 300 | 58.28 |
| 01:26 ET | 300 | 58.28 |
| 01:28 ET | 100 | 58.28 |
| 01:32 ET | 1100 | 58.22 |
| 01:33 ET | 11742 | 58.49 |
| 01:35 ET | 1700 | 58.45 |
| 01:37 ET | 400 | 58.53 |
| 01:44 ET | 888 | 58.41 |
| 01:46 ET | 1065 | 58.325 |
| 01:48 ET | 300 | 58.415 |
| 01:50 ET | 311 | 58.43 |
| 01:55 ET | 400 | 58.4 |
| 01:57 ET | 300 | 58.39 |
| 02:00 ET | 720 | 58.33 |
| 02:02 ET | 498 | 58.35 |
| 02:04 ET | 1207 | 58.29 |
| 02:06 ET | 4072 | 58.3 |
| 02:08 ET | 1100 | 58.27 |
| 02:09 ET | 800 | 57.96 |
| 02:11 ET | 806 | 57.96 |
| 02:13 ET | 1000 | 58.0775 |
| 02:15 ET | 100 | 58.17 |
| 02:20 ET | 200 | 58.155 |
| 02:22 ET | 120 | 58.12 |
| 02:24 ET | 240 | 58.14 |
| 02:26 ET | 633 | 58.16 |
| 02:27 ET | 201 | 58.145 |
| 02:29 ET | 300 | 58.19 |
| 02:31 ET | 400 | 58.19 |
| 02:33 ET | 200 | 58.13 |
| 02:40 ET | 440 | 58.155 |
| 02:42 ET | 600 | 58.08 |
| 02:44 ET | 113 | 58.09 |
| 02:45 ET | 1146 | 58.06 |
| 02:47 ET | 300 | 58.055 |
| 02:49 ET | 7989 | 58.195 |
| 02:51 ET | 200 | 58.395 |
| 02:54 ET | 300 | 58.42 |
| 02:56 ET | 220 | 58.425 |
| 02:58 ET | 700 | 58.405 |
| 03:00 ET | 753 | 58.34 |
| 03:02 ET | 314 | 58.3713 |
| 03:03 ET | 1171 | 58.51 |
| 03:05 ET | 569 | 58.45 |
| 03:07 ET | 100 | 58.51 |
| 03:09 ET | 1023 | 58.39 |
| 03:12 ET | 539 | 58.39 |
| 03:14 ET | 667 | 58.33 |
| 03:16 ET | 300 | 58.36 |
| 03:18 ET | 700 | 58.38 |
| 03:20 ET | 1100 | 58.4581 |
| 03:21 ET | 1294 | 58.57 |
| 03:23 ET | 500 | 58.59 |
| 03:25 ET | 973 | 58.53 |
| 03:27 ET | 348 | 58.53 |
| 03:30 ET | 1204 | 58.39 |
| 03:32 ET | 200 | 58.395 |
| 03:34 ET | 5076 | 58.32 |
| 03:36 ET | 306 | 58.28 |
| 03:38 ET | 316 | 58.29 |
| 03:39 ET | 700 | 58.28 |
| 03:41 ET | 400 | 58.275 |
| 03:43 ET | 800 | 58.275 |
| 03:45 ET | 3677 | 58.35 |
| 03:48 ET | 2258 | 58.24 |
| 03:50 ET | 1800 | 58.155 |
| 03:52 ET | 3833 | 58.19 |
| 03:54 ET | 4573 | 58.16 |
| 03:56 ET | 10256 | 58.195 |
| 03:57 ET | 12015 | 58.06 |
| 03:59 ET | 82332 | 57.96 |
Oct 16, 2024
Crinetics Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 12, 2024, from 8:00AM ET on Wednesday Oct 16, 2024 by Dow Jones
8:00AM ET on Wednesday Oct 16, 2024 by Dow Jones
Oct 10, 2024
Crinetics Pharmaceuticals Announces October 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 4:40PM ET on Thursday Oct 10, 2024 by Dow Jones
4:40PM ET on Thursday Oct 10, 2024 by Dow Jones
Oct 9, 2024
*DJ Crinetics Pharmaceuticals Prices Upsized Public Offering of Shares at $50 Each >CRNX, from 12:02AM ET on Wednesday Oct 09, 2024 by Dow Jones
12:02AM ET on Wednesday Oct 09, 2024 by Dow Jones
Oct 8, 2024
Crinetics Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock, from 11:55PM ET on Tuesday Oct 08, 2024 by Dow Jones
11:55PM ET on Tuesday Oct 08, 2024 by Dow JonesDJ Crinetics Pharmaceuticals Selling Up to $460M in Shares, from 4:14PM ET on Tuesday Oct 08, 2024 by Dow Jones
4:14PM ET on Tuesday Oct 08, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Crinetics Pharmaceuticals Inc | 5.2B | -15.4x | --- |
Biohaven Ltd | 5.2B | -5.8x | --- |
Avidity Biosciences Inc | 5.3B | -15.3x | --- |
Krystal Biotech Inc | 5.0B | 48.0x | --- |
Madrigal Pharmaceuticals Inc | 4.6B | -8.3x | --- |
BridgeBio Pharma Inc | 4.5B | -9.0x | --- |
Company Information
Crinetics Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its Paltusotine, an investigational, oral somatostatin receptor type 2 (SST2) agonist, is in Phase 3 clinical development for acromegaly and Phase 2 clinical development for carcinoid syndrome associated with neuroendocrine tumors. It has demonstrated pharmacologic proof-of-concept in a Phase 1 clinical study for CRN04894, an investigational, oral ACTH antagonist, that is in Phase 2 clinical studies for the treatment of congenital adrenal hyperplasia and Cushing's disease. Its drug candidates are orally delivered, small molecule new chemical entities resulting from in-house drug discovery efforts, including other programs addressing a variety of endocrine conditions such as hyperparathyroidism, polycystic kidney disease, Graves' disease, thyroid eye disease, diabetes and obesity.
Contact Information
- Headquarters
- 10222 Barnes Canyon Rd Bldg 2SAN DIEGO, CA, United States 92121-2711
- Phone
- 858-450-6464
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Wendell Wierenga
- Co-Founder, Director
- R. Scott Struthers
- Co-Founder, Chief Scientific Officer
- Stephen Betz
- Chief Financial Officer
- Marc Wilson
- Chief Operating Officer
- Jeff Knight
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $5.2B |
|---|---|
Revenue (TTM) | $1.4M |
Shares Outstanding | 89.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.63 |
EPS | $-3.77 |
Book Value | $7.91 |
P/E Ratio | -15.4x |
Price/Sales (TTM) | 3,738.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -20,068.38% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
